Moclobemide (Aurorix) in primary major depression. 1994

Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest, Hungary.

1. Moclobemide (Aurorix) is a newly developed, effective, short-acting well tolerable and safe antidepressant which belongs to the new class of reversible monoamine-oxidase-A inhibitors. 2. Aurorix was given per os in an open clinical trial for 6 weeks to 30 patients with DSM-III diagnoses of (nonpsychotic, nonmelancholic), major depression. 3. Out of the 25 patients who completed the study 14 (56%) were responders and 11 (44%) non-responders. 4. The patients tolerated the drug very well, and no serious side-effects were noted. 5. Pretreatment biological markers (dexamethasone suppression test, platelet-MAO-B activity, 3H-imipramine binding, thyroid function) did not have a predictive value regarding the drug response.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
May 1994, Revue medicale de Liege,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
August 1992, Nederlands tijdschrift voor geneeskunde,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
February 1991, Ugeskrift for laeger,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
January 1990, Acta psychiatrica Scandinavica. Supplementum,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
September 1994, Ugeskrift for laeger,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
August 1995, Journal of clinical psychopharmacology,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
October 1995, Acta psychiatrica Scandinavica,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
January 1994, Drug and therapeutics bulletin,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
January 1989, Journal of neural transmission. Supplementum,
Z Rihmer, and J Barsi, and G Vad, and S György, and B Zalay, and K Vég, and A Gábor
January 1992, Psychopharmacology,
Copied contents to your clipboard!